The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

Illegal drug sellers packaged deadly opioids into pills disguised as common prescription drugs and sold millions of them ...

The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.

H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Zevra Therapeutics (ZVRA – Research Report) today and set a price target ...

The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.

Richard Law CFA, an analyst from Goldman Sachs, has initiated a new Hold rating on Celldex (CLDX). Richard Law CFA has given his Hold rating ...